Arbutus Biopharma Corp
imdusiran
chronic hepatitis B
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on imdusiran for chronic hepatitis B is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“The FDA granted Fast Track designation for imdusiran for the treatment of chronic hepatitis B.”